Status:
COMPLETED
Improving Resection Rates Among African Americans With NSCLC
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Non-small Cell Lung Cancer (NSCLC)
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This is a randomized, interventional trial in which the navigation is the intervention. Phase is not applicable. The study is a randomized trial to evaluate the impact of a nurse-led patient navigatio...
Detailed Description
The burden to participants will be minimized to enhance retention. Patients in the usual care arm receive the current "gold standard" of treatment. The patients in the intervention arm are assigned to...
Eligibility Criteria
Inclusion
- AA race
- Clinically suspicious or biopsy-proven, early stage NSCLC, and
- Ages 21 years and older
Exclusion
- Previous history of lung cancer
- Spread of newly diagnosed probably/proven lung cancer to other part of the body
- Diagnosis of synchronous cancer other than non-melanoma skin cancer or lung cancer, and
- Receipt of surgical resection or radiosurgery for lung cancer since diagnosis with probable/proven lung cancer
Key Trial Info
Start Date :
April 23 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2019
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT01885455
Start Date
April 23 2015
End Date
September 9 2019
Last Update
May 12 2020
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Beebe Healthcare Tunnell Cancer Center
Lewes, Delaware, United States, 19958
2
Saint Joseph's/Candler Hospital
Savannah, Georgia, United States, 31405
3
Stroger Hospital of Cook County
Chicago, Illinois, United States, 60612
4
Ochsner NCORP
New Orleans, Louisiana, United States, 70121